No Data
No Data
Valneva Provides Update on ACIP Recommendation for Its Chikungunya Vaccine IXCHIQ Among U.S. Travelers
Kepler Capital Remains a Buy on Valneva (0OB3)
Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, Including a Presentation on Its Chikungunya Vaccine IXCHIQ
12 Analysts Assess Valneva: What You Need To Know
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Centene (CNC) and Soleno Therapeutics (SLNO)
Valneva Shares Leap on Brazilian Approval of Chikungunya Vaccine